Two Sigma Advisers’s Cantel Medical Corporation CMD Stock Holding History

Two Sigma Advisers’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-272,252	Closed	-$21.7M	–	2808
2021 Q1	$21.7M	Buy	+272,252	New	+$21.3M	0.06%	344
2018 Q4	–	Sell	-4,086	Closed	-$376K	–	2512
2018 Q3	$376K	Buy	+4,086	New	+$389K	﹤0.01%	1898
2015 Q2	–	Sell	-5,596	Closed	-$266K	–	2134
2015 Q1	$266K	Sell	5,596 -2,752	-33%	-$122K	﹤0.01%	1628
2014 Q4	$361K	Buy	+8,348	New	+$341K	﹤0.01%	1832

Two Sigma Advisers's CMD Position: Q2 2021 in Review

Two Sigma Advisers sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 272,252 shares — an estimated $21.7M sold.

Two Sigma Advisers first reported a position in CMD in Q4 2014 and held it in 4 quarters. The position peaked at $21.7M in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

Two Sigma Advisers reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
Two Sigma Advisers sold 272,252 Cantel Medical Corporation shares in Q2 2021, an estimated $21.7M.
Two Sigma Advisers first reported a position in Cantel Medical Corporation in Q4 2014 and held it in 4 quarters.
Two Sigma Advisers's Cantel Medical Corporation position peaked at $21.7M in Q1 2021.
0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Two Sigma Advisers's 13F filing for Q2 2021, filed 16 Aug 2021.